ASP Isotopes Inc. Common Stock
NASDAQ:ASPIChemicals
+$0.32 today
- Market cap
- $191.68M
- Beta
- 3.44
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.43
Volume 7.05M
Average 5.68M
ASPI Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
ASP Isotopes Inc. Common StockNASDAQ: ASPI
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $6.14M (cash outflow) rose 160.1% year over year, ahead of the +7.6% change in trailing-twelve-month capital expenditures. Sequentially, it rose 155.9% from the prior quarter. Over 3 fiscal years it compounded at +29.2% a year.
Context
- Capital expenditures amounted to 40.5% of revenue in FY2025, down 234.0 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +160.1% holds above the trailing-twelve-month pace of +7.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (9.65M) USD
- Year-over-year change
- +15.1%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (9.65M) | +15.1% |
| FY2024 | 2024-12-31 | (11.37M) | -387.8% |
| FY2023 | 2023-12-31 | (2.33M) | +47.9% |
| FY2022 | 2022-12-31 | (4.47M) | -49.7% |
| FY2021 | 2021-12-31 | (2.99M) | — |
Capital Expenditures vs competitors
How ASPI compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +7.6% is the 5th highest of 11, against a peer median of -3.0%.
- Capital expenditures amounts to 49.9% of revenue for ASPI, versus a peer median of 5.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$3.16B BRL | -10.8% | -14.1% | 4.7% | |
| LTM Mar 2026 | $298M USD | -26.2% | -90.7% | 10.2% | |
| LTM Mar 2026 | $177.13M USD | +356.6% | -25.9% | 7.6% | |
| LTM Mar 2026 | $74.9M USD | +4.9% | -10.3% | 5.8% | |
| LTM Mar 2026 | $68.42M USD | +24.0% | +13.4% | 5.5% | |
| LTM Mar 2026 | $58.29M USD | -21.7% | +5.0% | 4.2% | |
| LTM Mar 2026 | $39.53M USD | +3086.7% | +152.5% | 101.2% | |
| LTM Apr 2026 | $29M USD | -11.5% | +12.6% | 5.9% | |
| LTM Mar 2026 | $26.94M USD | -70.1% | -44.0% | 1.4% | |
| LTM Mar 2026 | $19.78M USD | +439.9% | -42.3% | 14.8% | |
| LTM Mar 2026 | $13.43M USD | +7.6% | +29.2% | 49.9% | |
| Peer median (excluding ASPI) | — | -3.0% | -12.2% | 5.9% | |
Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (2.61M) | (4.95M) | (16.29M) | (32.42M) | (159.84M) |
| Depreciation & Amortization | 19.38K | 72.57K | 37.43K | 471.42B | 1.91M |
| Deferred Income Tax | 0 | (72.57K) | 16.66K | (143.28K) | (45K) |
| Stock-Based Compensation | 0 | 2M | 8.74M | 8.56M | 16.02M |
| Change in Working Capital | (238.21K) | 33.89K | 1.16M | (2.62M) | (3.63M) |
| Accounts Receivables | 0 | 0 | 237.95K | (505.95K) | (454K) |
| Inventory | 0 | 0 | 0 | (67.64K) | (315K) |
| Accounts Payables | 59.68K | 570.6K | (224.6K) | (877.47K) | 782K |
| Other Working Capital | (297.89K) | (536.71K) | 1.15M | (1.17M) | (3.64M) |
| Other Non-Cash Items | 2.23M | (27.96K) | 924.12K | (471.41B) | 107.8M |
| Operating Cash Flow | (577.69K) | (2.94M) | (5.41M) | (16.7M) | (37.78M) |
| Capital Expenditures | (2.99M) | (4.47M) | (2.33M) | (11.37M) | (9.65M) |
| Acquisitions (Net) | 0 | 0 | (121.85K) | 0 | 25.37M |
| Purchases of Investments | 0 | 0 | 0 | 0 | (75.74M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (29.97M) |
| Investing Cash Flow | (2.99M) | (4.47M) | (2.45M) | (11.37M) | (90M) |
| Debt Repayment | 46.9K | (13.05K) | (180.53K) | 25.72M | 44.11M |
| Common Stock Issued | 6.45M | 8.12M | 14.13M | 53.09M | 307.09M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | (2.78T) | 0 |
| Other Financing Activities | 0 | (1.47M) | (563.47K) | 2.78T | (402K) |
| Financing Cash Flow | 6.5M | 6.64M | 13.39M | 82.53M | 350.8M |
| Effect of Forex Changes | 18.72K | 207.42K | (867) | (484.01K) | 646.95K |
| Net Change in Cash | 2.93M | (564.58K) | 5.52M | 53.98M | 223.67M |
| Free Cash Flow | (3.57M) | (7.41M) | (7.74M) | (28.07M) | (47.43M) |
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.